Guardant Health, Inc. Cash & Equivalents 2015-2026 | GH
What is cash & equivalents?
Cash and cash equivalents can be defined as the most liquid assets on a company's balance sheet, including cash on hand and short-term investments maturing within 90 days.
What is Guardant Health, Inc.'s current cash & equivalents?
Guardant Health, Inc. (GH) annual cash & equivalents for 2025 was $378.2M, a 28.04% decline from 2024. Guardant Health, Inc. cash & equivalents for the quarter ending March 31, 2026 was $989.3M.
What was Guardant Health, Inc.'s cash & equivalents in 2024?
Guardant Health, Inc. annual cash & equivalents for 2024 was $525.5M, a 53.64% decline from 2023.
What was Guardant Health, Inc.'s cash & equivalents in 2023?
Guardant Health, Inc. annual cash & equivalents for 2023 was $1.13B, a 700.36% increase from 2022.
What is Guardant Health, Inc.'s 5-year cash & equivalents CAGR?
Guardant Health, Inc. cash & equivalents grew at a compound annual growth rate (CAGR) of 14.61% from FY2020 to FY2025, going from $833.0M to $378.2M over 5 years.
Year-over-year comparison from 10-K annual reports